Lana J. McMillan

Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial

Paul Kim, Ana M. Sánchez, Taylor J.R. Penke et al. · The Lancet Infectious Diseases · 2024 · 83 citations

Life Sciences, Infectious Diseases, Microbiology +17

Multiplex quantitative SILAC for analysis of archaeal proteomes: a case study of oxidative stress responses

Lana J. McMillan, Sungmin Hwang, Rawan E. Farah et al. · Environmental Microbiology · 2017 · 35 citations · Full text

Life Sciences, Biochemistry, Microbiology +14

GlpR Is a Direct Transcriptional Repressor of Fructose Metabolic Genes in Haloferax volcanii

Jonathan H. Martin, Katherine S. Rawls, Jou Chin Chan et al. · Journal of Bacteriology · 2018 · 31 citations · Full text

Life Sciences, Microbiology, Molecular Biology +16

Archaeal Inorganic Pyrophosphatase Displays Robust Activity under High-Salt Conditions and in Organic Solvents

Lana J. McMillan, Nathaniel L. Hepowit, Julie A. Maupin‐Furlow · Applied and Environmental Microbiology · 2015 · 13 citations · Full text

Life Sciences, Biochemistry, Microbiology +15

Molecular Factors of Hypochlorite Tolerance in the Hypersaline Archaeon Haloferax volcanii

Miguel Gomez, Whinkie Leung, Swathi Dantuluri et al. · Genes · 2018 · 11 citations · Full text

Life Sciences, Microbiology, Molecular Biology +12